全文获取类型
收费全文 | 2850篇 |
免费 | 169篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 103篇 |
妇产科学 | 98篇 |
基础医学 | 377篇 |
口腔科学 | 68篇 |
临床医学 | 245篇 |
内科学 | 669篇 |
皮肤病学 | 33篇 |
神经病学 | 148篇 |
特种医学 | 209篇 |
外国民族医学 | 2篇 |
外科学 | 432篇 |
综合类 | 38篇 |
预防医学 | 166篇 |
眼科学 | 27篇 |
药学 | 110篇 |
中国医学 | 6篇 |
肿瘤学 | 285篇 |
出版年
2023年 | 23篇 |
2022年 | 25篇 |
2021年 | 75篇 |
2020年 | 24篇 |
2019年 | 46篇 |
2018年 | 68篇 |
2017年 | 61篇 |
2016年 | 48篇 |
2015年 | 60篇 |
2014年 | 94篇 |
2013年 | 122篇 |
2012年 | 156篇 |
2011年 | 168篇 |
2010年 | 114篇 |
2009年 | 114篇 |
2008年 | 151篇 |
2007年 | 191篇 |
2006年 | 144篇 |
2005年 | 131篇 |
2004年 | 137篇 |
2003年 | 154篇 |
2002年 | 133篇 |
2001年 | 55篇 |
2000年 | 44篇 |
1999年 | 47篇 |
1998年 | 58篇 |
1997年 | 64篇 |
1996年 | 49篇 |
1995年 | 47篇 |
1994年 | 22篇 |
1993年 | 25篇 |
1992年 | 20篇 |
1991年 | 27篇 |
1990年 | 25篇 |
1989年 | 31篇 |
1988年 | 29篇 |
1987年 | 29篇 |
1986年 | 20篇 |
1985年 | 20篇 |
1984年 | 16篇 |
1983年 | 15篇 |
1982年 | 21篇 |
1981年 | 14篇 |
1980年 | 17篇 |
1979年 | 7篇 |
1978年 | 14篇 |
1977年 | 13篇 |
1976年 | 11篇 |
1975年 | 10篇 |
1969年 | 5篇 |
排序方式: 共有3045条查询结果,搜索用时 15 毫秒
31.
Francine Walker Stéphanie Kermorgant Emile Dara? Patrick Madelenat Anne Claude Cremieux Dominique Hénin Thérèse Lehy 《Clinical cancer research》2003,9(1):273-284
PURPOSE: High prevalence of squamous cervical intraepithelial neoplasia (CIN) linked to oncogenic human papillomavirus (HPV) exits in HIV-infected women. Hepatocyte growth factor (HGF) and its receptor, c-Met, promote cell proliferation and are involved in tumor progression. Nothing is yet known about their expression in low- and high-grade CIN. Therefore, the expression, localization, and behavior of HGF and c-Met in normal and dysplastic cervical epithelium were investigated. EXPERIMENTAL DESIGN: We studied normal cervical mucosa from 10 healthy women, and low- and high-grade cervical lesions, uninfected (condyloma acuminata) or infected with oncogenic HPVs, from 40 HIV-negative and 48 HIV-positive women, using in situ molecular techniques, immunocytochemistry and morphoquantitative methods. RESULTS: In 154 oncogenic HPV-infected CIN encountered in biopsy samples, the total number of epithelial cell layers increased significantly during lesion progression. This number was significantly higher in HIV-positive than in HIV-negative women for CIN1 and CIN2 (P < 0.025 to P < 0.01). In HIV-negative women, the number and percentage of HGF and c-Met immunostained cell layers, and the intensity of immunostaining were enhanced in oncogenic HPV-infected lesions as compared with normal mucosa and condyloma acuminata. The latter parameters were significantly higher in tissues of HIV-positive women (oncogenic HPV-infected CIN1 and CIN2, normal-appearing mucosa contiguous to CIN, condyloma acuminata) than in the corresponding tissues of HIV-negative women (P < 0.025 to P < 0.0001). CONCLUSIONS: Overexpression of HGF/c-Met complex strongly correlates with oncogenic HPV and HIV infection. This overexpressed complex may stimulate cell proliferation in condyloma acuminata and participate in tumor progression in oncogenic HPV-infected lesions. 相似文献
32.
van Kranen HJ; van Iersel PW; Rijnkels JM; Beems DB; Alink GM; van Kreijl CF 《Carcinogenesis》1998,19(9):1597-1601
The variation in colorectal cancer (CRC) incidence worldwide strongly
suggests a role for dietary influences. Based on epidemiological data,
protective effects of vegetables and fruit intake on CRC are widely
claimed, while other data indicate a possible increased CRC risk from
(higher) dietary fat intake. Therefore, we have investigated single and
interactive effects of dietary fat and a vegetable-fruit mixture (VFM) in
the ApcMin mouse, a mouse model for multiple intestinal neoplasia. In this
study, four different diets (A-D) were compared, which were either low in
fat (20% energy diets A/B) or high in fat (40% energy diets C/D). In
addition, 19.5% (wt/wt) of the carbohydrates in diets B and D were replaced
by a freeze-dried VFM. The diets were balanced so that they only differed
among each other in fat/carbohydrate content and the presence of specific
plant-constituents. Because the initiation of intestinal tumors in ApcMin
mice occurs relatively early in life, exposure to the diets was started in
utero. Without the addition of VFM, mice maintained at a high-fat diet did
not develop significantly higher numbers of small or large intestinal
adenomas than mice maintained at a low-fat diet. VFM added to a low-fat
diet significantly lowered multiplicity of small intestinal polyps (from
16.2 to 10.2/mouse, 15 animals/group), but not of colon tumors in male
ApcMin mice only. Strikingly, addition of VFM to female mice maintained on
a low-fat diet and to both sexes maintained on a high-fat diet
significantly enhanced intestinal polyp multiplicity (from 16.5 to 26.7
polyps/mouse). In conclusion, our results indicate that neither a lower fat
intake nor consumption of VFM included in a high-fat diet decreases the
development of polyps in mice genetically predisposed to intestinal tumor
development.
相似文献
33.
This review describes European health policies related to the place of birth of very preterm babies, and the organizational context in which these policies were enacted using data from two European studies. It also compiles available information on the place of birth of very preterm babies from the published literature. In Europe, there is significant diversity in approaches to the provision of intensive care services for the small proportion of pregnant women and babies that need it, both in terms of health policies and the supply and characteristics of maternity and neonatal units. These diverse models in countries with similar levels of development and medical technology could offer an opportunity to understand how different organizational characteristics affect access to care, health outcomes and resource use. 相似文献
34.
Peter Nieboer Ciska Buijs Sjoerd Rodenhuis Caroline Seynaeve Louk V A M Beex Elsken van der Wall Dick J Richel Marianne A Nooij Emile E Voest Pierre Hupperets Nanno H Mulder Winette T A van der Graaf Els M TenVergert Harm van Tinteren Elisabeth G E de Vries 《Journal of clinical oncology》2005,23(33):8296-8304
PURPOSE: Determine whether standard or high-dose chemotherapy leads to changes in fatigue, hemoglobin (Hb), mental health, muscle and joint pain, and menopausal status from pre- to post-treatment and to evaluate whether fatigue is associated with these factors in disease-free breast cancer patients. PATIENTS AND METHODS: Eight hundred eighty-five patients were randomly assigned between two chemotherapy regimens both followed by radiotherapy and tamoxifen. Fatigue was assessed using vitality scale (score < or = 46 defined as fatigue), poor mental health using mental health scale (score < or = 56 defined as poor mental health) both of Short-Form 36, muscle and joint pain with Rotterdam Symptom Checklist, and Hb levels were assessed before and 1, 2, and 3 years after chemotherapy. RESULTS: Fatigue was reported in 20% of 430 assessable patients (202 standard-dose, 228 high-dose) with at least a 3-year follow-up, without change over time or difference between treatment arms. Mean Hb levels were lower following high-dose chemotherapy. Only 5% of patients experienced fatigue and anemia. Mental health score was the strongest fatigue predictor at all assessment moments. Menopausal status had no effect on fatigue. Linear mixed effect models showed that the higher the Hb level (P = .0006) and mental health score (P < .0001), the less fatigue was experienced. Joint (P < .0001) and muscle pain (P = .0283) were associated with more fatigue. CONCLUSION: In 3 years after treatment, no significant differences in fatigue were found between standard and high-dose chemotherapy. Fatigue did not change over time. The strongest fatigue predictor was poor mental health. 相似文献
35.
36.
Transesophageal echocardiography for the assessment of left atrial appendage thrombus: Study of the additional value of systematic real time 3D imaging after regular 2D evaluation 下载免费PDF全文
37.
38.
39.
Despoina Koulenti Andrew Song Aaron Ellingboe Mohd Hafiz Abdul-Aziz Patrick Harris Emile Gavey Jeffrey Lipman 《International journal of antimicrobial agents》2019,53(3):211-224
The spread of multidrug-resistant bacteria is an ever-growing concern, particularly among Gram-negative bacteria because of their intrinsic resistance and how quickly they acquire and spread new resistance mechanisms. Treating infections caused by Gram-negative bacteria is a challenge for medical practitioners and increases patient mortality and cost of care globally. This vulnerability, along with strategies to tackle antimicrobial resistance development, prompts the development of new antibiotic agents and exploration of alternative treatment options. This article summarises the new antibiotics that have recently been approved for Gram-negative bacterial infections, looks down the pipeline at promising agents currently in phase I, II, or III clinical trials, and introduces new alternative avenues that show potential in combating multidrug-resistant Gram-negative bacteria. 相似文献
40.